Cera™ VSD Occluder Post Market Clinical Follow-up

NCT05939713 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 152

Last updated 2025-06-12

No results posted yet for this study

Summary

The objective of this post-market registry is to assess the safety and performance of the Lifetech Cera™ VSD occluder in a real-world and on-label fashion.

Conditions

  • Ventricular Septal Defect

Interventions

DEVICE

Cera™ VSD occluder implantation

To collect data from patients who have implanted with the device before 2022.

Sponsors & Collaborators

  • Cardiac Children's Foundation Taiwan

    lead OTHER

Principal Investigators

  • Jou-Kou Wang · National Taiwan University Hospital

Eligibility

Min Age
3 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-13
Primary Completion
2025-03-04
Completion
2025-03-04

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05939713 on ClinicalTrials.gov